ELEKTA RECEIVES ORDERS FOR LEKSELL GAMMA KNIFE IN THE U.S., JAPAN AND ITALY VALUED AT SEK 160 MILLION

ELEKTA RECEIVES ORDERS FOR LEKSELL GAMMA KNIFE IN THE U.S., JAPAN AND ITALY VALUED AT SEK 160 MILLION Elekta has signed agreements to deliver Leksell Gamma Knife(R) equipment to the U.S., Japan and Italy. The agreements include delivery of Leksell Gamma Knife equipment and upgrade and reload of existing installations. The total order value is approximately SEK 160 million. The deliveries are planned for 2002-2004. One of the deliveries to the U.S. involves a unique prefabricated treatment room for Leksell Gamma Knife. The radiation-proof treatment room is being delivered turnkey, including all internal installations such as electrical, water, drains and ventilation. The hospital only needs to construct a concrete foundation for placement of the treatment room adjacent to the existing hospital buildings. "This installation solution offers a number of advantages for the customer as well as Elekta," says Tomas Puusepp, responsible for Elekta's sales, marketing and service. "Installation time is reduced to a few weeks. This means that the hospital can begin treatment of patients much earlier, which is important from a financial and competitive viewpoint. Placement of the installation is flexible and any disturbance in the hospital's daily operations is minimized, This is a new - and for our customers valuable - addition to Elekta's total solutions strategy. Elekta also has better control over the quality of the entire installation process," concludes Tomas Puusepp. ***** Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient. For further information, please contact: Lars Jonsteg, VP Communications, Elekta AB (publ), tel. +46 8 587 254 82 More information about Elekta can be found at: www.elekta.com ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2002/08/21/20040826BIT21510/wkr0001.pdf

About Us

For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

Subscribe

Documents & Links